Lunit's artificial intelligence (AI) mammography image analysis solution 'Lunit Insight MMG' (Photo by Lunit)

Lunit's artificial intelligence (AI) mammography image analysis solution 'Lunit Insight MMG' (Photo by Lunit)

View original image

[Asia Economy Reporter Chunhee Lee] Lunit announced on the 25th that its mammography image analysis solution, 'Lunit Insight MMG,' recently obtained medical device sales approval (Class Ⅱ Medical Device) from the Taiwan Food and Drug Administration (TFDA).


Lunit Insight MMG is an artificial intelligence (AI)-based product that detects the presence of breast cancer in mammography images. It detects suspicious areas with 96% accuracy and assists medical professionals by providing location information and numerical indicators of the suspicion level. Lunit Insight MMG previously received sales approval from major countries, including the U.S. Food and Drug Administration (FDA) last year and Health Canada in June.


The Taiwanese medical device market is gradually expanding due to an increasing elderly population and a growing proportion of imported advanced medical devices. As of last year, the Taiwanese medical device market size was 77.785 billion Taiwan dollars (approximately 3.4389 trillion Korean won), maintaining an annual growth rate of about 3%.


Dr. Ye Wei-cheng of Nantou Hospital in Taiwan, who is currently using Lunit Insight MMG, stated, "We decided to adopt Lunit Insight MMG to increase the speed of mammography interpretation and reduce the possibility of misdiagnosis." He added, "Lunit Insight MMG is particularly effective for diagnosing dense breasts, which are common among East Asian women, and it facilitates accurate and smooth communication among specialists."



Seobum Seok, CEO of Lunit, said, "Lunit Insight MMG provides patients with opportunities for fast and accurate treatment while simultaneously improving the convenience of medical professionals." He added, "This sales approval in Taiwan is expected to serve as a foothold for expanding into the Greater China market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing